Knowledge Center
Article / Aug 30, 2016
Accelerating approval and reducing costs of spray dried drugs through development by design
Source:
Pharma's Almanac, Global Pharmaceutical Supply Chain Trends, Q3 2016
Contract development and manufacturing organizations with unique technical capabilities and expertise are able to speed up the development and commercialization of novel medicines. Effective application of its extensive knowledge, data base and Development by Design approach has enabled Hovione to accelerate spray drying development, simultaneously reducing cost and time to get challenging drugs to patients in need.
Related links
Also in the Knowledge Center
/ Oct 05, 2023
Inhalable pharmaceutical composition containing spray dried cohesive composite active particles and carrier based formulation combination
Read more
Scientific Article
/ Nov 30, 2023
Webinar - Nasal powder delivery: Process, formulation and analytical characterization
Read more
Scientific Article
Scientific Article